. 2018 Mar 7;178(5):523–531. doi: 10.1530/EJE-17-0882
This work is licensed under a Table 1.
Characteristics of the study participants. Data presented as mean ± s.d.
| Men | Women | All | P (men vs women) | |
|---|---|---|---|---|
| Number of participants | 216 | 110 | 326 | |
| Age (years) | 40.2 ± 15.3 | 53.4 ± 16.8 | 44.6 ± 17.0 | <0.001 |
| Body mass index (kg/m2) | 26.8 ± 5.1 | 28.7 ± 7.4 | 27.4 ± 6.0 | 0.170 |
| Fasting plasma glucose (mmol/L) | 5.5 ± 0.5 | 5.6 ± 0.6 | 5.6 ± 0.5 | 0.907 |
| Fasting serum insulin (μU/mL) | 8.8 ± 6.2 | 8.9 ± 6.5 | 8.8 ± 6.3 | 0.815 |
| Whole body GU (µmol/kg body weight/min) | 28.7 ± 15.4 | 26.0 ± 13.0 | 27.8 ± 14.7 | 0.228 |
| Femoral skeletal muscle GU (µmol/tissue kg/min) | 42.9 ± 27.0 | 46.6 ± 29.7 | 44.1 ± 27.9 | 0.397 |
| Liver GU (µmol/tissue kg/min) | 21.7 ± 8.2 | 23.2 ± 10.2 | 22.4 ± 9.2 | 0.380 |
| Subcutaneous adipose tissue GU (µmol/tissue kg/min) | 10.9 ± 6.7 | 12.5 ± 7.0 | 11.6 ± 6.8 | 0.054 |
| Intraperitoneal adipose tissue GU (µmol/tissue kg/min) | 18.0 ± 10.2 | 24.9 ± 12.4 | 21.3 ± 11.8 | <0.001 |
| Endogenous glucose production (µmol/kg body weight/min) | 7.0 ± 6.3 | 3.1 ± 4.6 | 5.1 ± 5.9 | <0.001 |
GU, glucose uptake.